// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
The scale and speed of the global vaccine research and development effort in response to COVID-19